ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

RANI Rani Therapeutics Holdings Inc

1.5988
0.1388 (9.51%)
04 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Rani Therapeutics Holdings Inc NASDAQ:RANI NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.1388 9.51% 1.5988 1.32 2.02 1.61 1.45 1.45 525,099 05:00:05

Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit

08/10/2024 9:05pm

GlobeNewswire Inc.


Rani Therapeutics (NASDAQ:RANI)
Historical Stock Chart


From Oct 2024 to Jan 2025

Click Here for more Rani Therapeutics Charts.

 Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that the company’s Chief Executive Officer, Talat Imran, and Chief Financial Officer, Svai Sanford, will participate in a fireside chat at the 2024 Maxim Healthcare Virtual Summit on Thursday, October 17, 2024 from 11:30 am – 12:00 pm E.T. in Track 2.

Interested parties can register and access the live webcast for the conference here.

About Rani Therapeutics

Rani Therapeutics is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. Rani has developed the RaniPill® capsule, which is a novel, proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. Rani has successfully conducted several preclinical and clinical studies to evaluate safety, tolerability and bioavailability using RaniPill® capsule technology. For more information, visit ranitherapeutics.com.

Investor Contact:

investors@ranitherapeutics.com

Media Contact:

media@ranitherapeutics.com

1 Year Rani Therapeutics Chart

1 Year Rani Therapeutics Chart

1 Month Rani Therapeutics Chart

1 Month Rani Therapeutics Chart

Your Recent History

Delayed Upgrade Clock